Literature DB >> 16342102

Effects of supervised cardiovascular training program on exercise tolerance, aerobic capacity, and quality of life in patients with systemic lupus erythematosus.

Maria Rosenilda P de Carvalho1, Emilia I Sato, Antonio S Tebexreni, Raquel T C Heidecher, Simone Schenkman, Turíbio L Barros Neto.   

Abstract

OBJECTIVE: To determine if supervised cardiovascular training improves exercise tolerance, aerobic capacity, depression, functional capacity, and quality of life in patients with systemic lupus erythematosus (SLE).
METHODS: Sixty women with SLE (ages 18-55 years) were evaluated using Short Form 36, visual analog scale for pain, scale for fatigue, Beck Depression Inventory, and Health Assessment Questionnaire (HAQ), and participated in a training protocol of incremental load on a treadmill with computed gas metabolic analysis. Maximum oxygen consumption (VO(2max)) and anaerobic threshold VO(2) were calculated with a SensorMedics Vmax29C analyzer (Sensor Medics, Yorba Linda, CA), and heart rate was measured by electrocardiogram. Patients were divided into 2 groups: a training group (41 patients) that participated in the supervised cardiovascular training program and a control group (19 patients) that did not participate in the program. All variables were analyzed at baseline and after 12 weeks for both groups. The training program occurred in the morning for 60 minutes, 3 times a week for 12 weeks. Statistical analysis included Wilcoxon's rank sum test, Mann-Whitney U test, chi-square test, and Fisher's exact test. P values <0.05 were considered to be statistically significant.
RESULTS: The 2 groups were homogeneous and comparable at baseline. The training group showed a significant improvement of aerobic capacity measured by anaerobic threshold VO(2) (14.67 +/- 3.03 versus 17.08 +/- 3.35 ml/kg/minute, P < 0.001). Comparison of the training group and control group after 12 weeks showed a significant difference relating to VO(2max) (24.31 +/- 4.61 versus 21.21 +/- 3.88 ml/kg/minute, P = 0.01) and anaerobic threshold VO(2) (17.08 +/- 3.35 versus 13.66 +/- 2.82 ml/kg/minute, P < 0.0001). After cardiovascular training, we found a significant improvement of Beck inventory score (8.37 +/- 12.79 versus 2.90 +/- 3.00, P < 0.001) and HAQ score (0.14 +/- 0.21 versus 0.06 +/- 0.19, P < 0.01) in the training group.
CONCLUSION: This study showed significant improvement in exercise tolerance, aerobic capacity, quality of life, and depression after a supervised cardiovascular training program in patients with SLE.

Entities:  

Mesh:

Year:  2005        PMID: 16342102     DOI: 10.1002/art.21605

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  22 in total

1.  Fatigue in systemic lupus erythematosus.

Authors:  Grace E Ahn; Rosalind Ramsey-Goldman
Journal:  Int J Clin Rheumtol       Date:  2012-04-01

2.  [Sports and exercise therapy in inflammatory rheumatic diseases].

Authors:  Wolfgang Hartung; Philipp Sewerin; Benedikt Ostendorf
Journal:  Z Rheumatol       Date:  2021-03-08       Impact factor: 1.372

3.  The implication of tissue Doppler echocardiography and cardiopulmonary exercise in early detection of cardiac dysfunction in systemic lupus erythematosus patients.

Authors:  Basant M Elnady; Ayman Saeed Mohamed Abdelghafar; El Shazly Abdul Khalik; Mohammed Mesfer Algethami; A S Basiony; Mona Dhaif Allah Al-Otaibi; Maram Eidhah Al-Otaibi
Journal:  Eur J Rheumatol       Date:  2016-09-01

4.  Peripheral and central mechanisms of fatigue in inflammatory and noninflammatory rheumatic diseases.

Authors:  Roland Staud
Journal:  Curr Rheumatol Rep       Date:  2012-12       Impact factor: 4.592

5.  Fatigue, patient reported outcomes, and objective measurement of physical activity in systemic lupus erythematosus.

Authors:  M A Mahieu; G E Ahn; J S Chmiel; D D Dunlop; I B Helenowski; P Semanik; J Song; S Yount; R W Chang; R Ramsey-Goldman
Journal:  Lupus       Date:  2016-02-10       Impact factor: 2.911

6.  Excess weight and associated risk factors in patients with systemic lupus erythematosus.

Authors:  Fabiana de Miranda Moura dos Santos; Mariane Curado Borges; Rosa Weiss Telles; Maria Isabel T D Correia; Cristina Costa Duarte Lanna
Journal:  Rheumatol Int       Date:  2012-04-22       Impact factor: 2.631

7.  Management of cardiovascular complications in systemic lupus erythematosus.

Authors:  Carly Skamra; Rosalind Ramsey-Goldman
Journal:  Int J Clin Rheumtol       Date:  2010-02-01

8.  Supervised walking improves cardiorespiratory fitness, exercise tolerance, and fatigue in women with primary Sjögren's syndrome: a randomized-controlled trial.

Authors:  Samira Tatiyama Miyamoto; Valéria Valim; Luciana Carletti; Wan-Fai Ng; Anselmo José Perez; Dennis William Lendrem; Michael Trennel; Raquel Altoé Giovelli; Laiza Hombre Dias; Érica Vieira Serrano; Alice Mendonça Subtil; Vanessa Cândido Abreu; Jamil Natour
Journal:  Rheumatol Int       Date:  2019-01-02       Impact factor: 2.631

9.  An individualized rehabilitation program in patients with systemic sclerosis may improve quality of life and hand mobility.

Authors:  Chiara M Antonioli; Giovanni Bua; Anna Frigè; Katia Prandini; Sara Radici; Mirko Scarsi; Elisabetta Danieli; Andrea Malvicini; Paolo Airo
Journal:  Clin Rheumatol       Date:  2008-09-16       Impact factor: 2.980

10.  Heat-Killed Lactobacillus reuteri GMNL-263 Inhibits Systemic Lupus Erythematosus-Induced Cardiomyopathy in NZB/W F1 Mice.

Authors:  Peng Xiang; Chih-Yang Huang; Yu-Lan Yeh; Min-Chi Lu; Bruce Chi-Kang Tsai; Bor-Show Tzang; Shiu-Min Cheng; Xiaoyong Zhang; Liang-Yo Yang; B Mahalakshmi; Wei-Wen Kuo
Journal:  Probiotics Antimicrob Proteins       Date:  2021-02       Impact factor: 4.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.